GALNTL6 and hepatocellular carcinoma: The clinical weight of this unique lncRNA was first reported in hepatocellular carcinoma [52] and gastric cancer patients with low-expressed linc-GALNTL6-4 [53], which indicated the worst prognosis and survival rates.